NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • DE • USD
Mainz Biomed B.V. (MYNZ) has a consensus analyst rating of Hold, based on 3 analysts covering the stock. Of those, 1 recommend buying, 2 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
